Literature DB >> 33727782

In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets.

Chidi Edbert Duru1, Ijeoma Akunna Duru2, Abayomi Emmanuel Adegboyega3,4.   

Abstract

BACKGROUND: The growing number of cases, severity and fatality of the COVID-19 pandemic, coupled with the fact that no cure has been found has made infected individuals especially in Africa, to resort to the consumption of different natural products to alleviate their condition. One of such plant materials that have been consumed to remedy the severity of this viral infection is the oil of Nigella sativa seed commonly called black seed oil. In this study, we extracted and characterized the oil from this seed using gas chromatography coupled to a mass selective detector to identify the component phytochemicals. Site-directed multiligand docking of the identified compounds was performed on SARS-CoV-2 molecular targets- Replicase polyprotein 1a, RNA binding protein of NSP9, ADP ribose phosphatase of NSP3, 3-chymotrypsin-like protease 3CLpro, and RNA-dependent RNA polymerase RDRP, and ACE2-angiotensin-converting enzyme from the Homo sapiens.
RESULTS: The binding affinity of caryophyllene oxide was the highest on 3CLpro (- 6.0 kcal/mol), NSP3 (- 6.3 kcal/mol), NSP9 (- 6.3 kcal/mol), and RDRP (- 6.9 kcal/mol) targets, while α-bergamotene gave the best binding affinity on RPIA (5.7 kcal/mol) target. The binding affinity of β-bisabolene on the ACE2 target (- 8.0 kcal/mol) was almost the same as Remdesivir (- 8.1 kcal/mol). The ADMET properties of these three phytochemicals showed that they are good drug leads for these SARS-CoV-2 receptors.
CONCLUSION: The findings from this study strongly indicate that the reported recovery from COVID-19 infection claimed by patients who consumed black seed oil could be linked to the presence of caryophyllene oxide, α-bergamotene, and β-bisabolene in this natural product.
© The Author(s) 2021.

Entities:  

Keywords:  Angiotensin-converting enzyme; Binding affinity; Nigella sativa; SARS-CoV-2; β-bisabolene

Year:  2021        PMID: 33727782      PMCID: PMC7952832          DOI: 10.1186/s42269-021-00517-x

Source DB:  PubMed          Journal:  Bull Natl Res Cent        ISSN: 1110-0591


  28 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties.

Authors:  Hongbin Yang; Chaofeng Lou; Lixia Sun; Jie Li; Yingchun Cai; Zhuang Wang; Weihua Li; Guixia Liu; Yun Tang
Journal:  Bioinformatics       Date:  2019-03-15       Impact factor: 6.937

3.  GC-MS Analysis of Bio-active Molecules Derived from Paracoccus pantotrophus FMR19 and the Antimicrobial Activity Against Bacterial Pathogens and MDROs.

Authors:  I Faridha Begum; R Mohankumar; M Jeevan; K Ramani
Journal:  Indian J Microbiol       Date:  2016-07-20       Impact factor: 2.461

4.  Analgesic and anti-inflammatory activity of Caryophyllene oxide from Annona squamosa L. bark.

Authors:  M J Chavan; P S Wakte; D B Shinde
Journal:  Phytomedicine       Date:  2009-07-02       Impact factor: 5.340

5.  Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.

Authors:  Zhenming Jin; Xiaoyu Du; Yechun Xu; Yongqiang Deng; Meiqin Liu; Yao Zhao; Bing Zhang; Xiaofeng Li; Leike Zhang; Chao Peng; Yinkai Duan; Jing Yu; Lin Wang; Kailin Yang; Fengjiang Liu; Rendi Jiang; Xinglou Yang; Tian You; Xiaoce Liu; Xiuna Yang; Fang Bai; Hong Liu; Xiang Liu; Luke W Guddat; Wenqing Xu; Gengfu Xiao; Chengfeng Qin; Zhengli Shi; Hualiang Jiang; Zihe Rao; Haitao Yang
Journal:  Nature       Date:  2020-04-09       Impact factor: 49.962

6.  Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone.

Authors:  Yen-Chi Tsao; Yu-Jung Chang; Chun-Hsien Wang; Linyi Chen
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

Review 7.  Nigella sativa L. (Black Cumin): A Promising Natural Remedy for Wide Range of Illnesses.

Authors:  Ebrahim M Yimer; Kald Beshir Tuem; Aman Karim; Najeeb Ur-Rehman; Farooq Anwar
Journal:  Evid Based Complement Alternat Med       Date:  2019-05-12       Impact factor: 2.629

8.  Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis.

Authors:  Jodie L Guy; Richard M Jackson; Hanne A Jensen; Nigel M Hooper; Anthony J Turner
Journal:  FEBS J       Date:  2005-07       Impact factor: 5.542

9.  Effect of Nigella sativa fixed and essential oils on antioxidant status, hepatic enzymes, and immunity in streptozotocin induced diabetes mellitus.

Authors:  Muhammad Tauseef Sultan; Masood Sadiq Butt; Roselina Karim; Shahzad Zafar Iqbal; Shakeel Ahmad; Muhammad Zia-Ul-Haq; Luigi Aliberti; Atif Nisar Ahmad; Vincenzo De Feo
Journal:  BMC Complement Altern Med       Date:  2014-06-17       Impact factor: 3.659

10.  Antioxidant activity and calcium binding of isomeric hydroxybenzoates.

Authors:  Zichen Zhao; Martina Vavrusova; Leif Horsfelt Skibsted
Journal:  J Food Drug Anal       Date:  2017-07-26       Impact factor: 6.157

View more
  3 in total

Review 1.  Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies.

Authors:  Sarah Mousavi; Shima Zare; Mahmoud Mirzaei; Awat Feizi
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-09-25       Impact factor: 2.585

Review 2.  Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature.

Authors:  Mohd Imran; Shah Alam Khan; Mohammed Kanan Alshammari; Saif M Alkhaldi; Fayez Nafea Alshammari; Mehnaz Kamal; Ozair Alam; Syed Mohammed Basheeruddin Asdaq; A Khuzaim Alzahrani; Shahamah Jomah
Journal:  Molecules       Date:  2022-04-25       Impact factor: 4.927

Review 3.  Natural Products and Nanotechnology Against Coronavirus Disease 2019.

Authors:  Ning Zeng; Xue Chen; Zeming Liu
Journal:  Front Chem       Date:  2022-02-10       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.